| Vijay Kumar Agarwal, MD | |
|
601 W 2nd St, Bloomington, IN 47403 | |
| (812) 676-4542 | |
| Not Available |
| Full Name | Vijay Kumar Agarwal |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 601 W 2nd St, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972736023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 200801438 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 01082301A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nash General Hospital | Rocky mount, NC | Hospital |
| Wakemed, Cary Hospital | Cary, NC | Hospital |
| Vidant Medical Center | Greenville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wakemed Specialists Group Llc | 2466788377 | 690 |
| Cogent Healthcare Of North Carolina Pc | 7911954714 | 123 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Wake Forest Health Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477785756 PECOS PAC ID: 4183538895 Enrollment ID: O20031117000868 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | High Point Regional Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396746228 PECOS PAC ID: 8426968371 Enrollment ID: O20031224000051 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Hugh Chatham Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447373063 PECOS PAC ID: 2062311442 Enrollment ID: O20040717000340 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Cogent Healthcare Of North Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548207483 PECOS PAC ID: 7911954714 Enrollment ID: O20050404001057 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of North Carolina - Rocky Mount |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619456894 PECOS PAC ID: 0547512139 Enrollment ID: O20181009003264 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Entity Name | Wakemed Specialists Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588227839 PECOS PAC ID: 2466788377 Enrollment ID: O20190731000815 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vijay Kumar Agarwal, MD Po Box 1329, Bloomington, IN 47402-1329 Ph: (812) 676-4542 | Vijay Kumar Agarwal, MD 601 W 2nd St, Bloomington, IN 47403 Ph: (812) 676-4542 |
News Archive
Scientists at Galileo Pharmaceuticals, Inc. have demonstrated a direct relationship between inflammation and glucose levels. Through its recently established metabolic disease program, Galileo confirmed in preclinical models that inhibiting lipoxygenases, known mediators of inflammatory response, significantly lowers blood glucose levels in animal models of diabetes.
A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
The holiday season is filled with festivities and family gatherings, but for some people this season can also be very stressful. Sometimes we need help to cope or stay safe and healthy.
The American Society of Nuclear Cardiology (www.asnc.org) released preliminary results from a survey of its membership today, which show that the impending cuts to cardiovascular services outlined in the Medicare Physician Fee Schedule will force widespread layoffs, office closures, and limited imaging services. These actions will ultimately lead to reduced access to imaging tests and more expensive care for America's seniors.
Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).
› Verified 4 days ago
Wai Pok Vernon Chan, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-676-4102 Fax: 812-676-4106 | |
Dr. Kevin Edward Zawacki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1312 W. Arch Haven Avenue, Bloomington, IN 47403 Phone: 812-676-4144 Fax: 812-339-8344 | |
Mr. Rana Zouveenoor Tariq, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1312 W Arch Haven Ave, Bloomington, IN 47403 Phone: 812-676-4144 | |
Dr. Samuel W Kimani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 | |
Dr. Simeon Zou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 583 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-676-4460 Fax: 812-355-4092 | |
Shelby Renee Tipton, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2905 N Stone Carver Dr, Bloomington, IN 47404 Phone: 812-676-4715 | |
Ms. Louise Anne Owens, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 S Madison St, Bloomington, IN 47403 Phone: 812-334-3303 Fax: 812-334-0842 |